Left ventricular aneurysm risk factors: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
Line 3: Line 3:
{{CMG}};{{AE}}{{MehdiP}}
{{CMG}};{{AE}}{{MehdiP}}
==Overview==
==Overview==
The common risk factors for developing LV aneurysm include [[ST elevation myocardial infarction|ST elevation MI]], [[hypertrophic cardiomyopathy]] (HCM), [[dilated cardiomyopathy]] (DCM), advanced age and [[hypertension]].
The common risk factors for developing LV aneurysm include [[ST elevation myocardial infarction|ST elevation MI]], [[hypertrophic cardiomyopathy]] (HCM), [[dilated cardiomyopathy]] (DCM), advanced age, and [[hypertension]].
==Risk Factors==
==Risk Factors==
The most potent risk factor for development of the LV aneurysm is '''[[ST elevation myocardial infarction|ST elevation MI]]'''. Other risk factors include:<ref name="pmid19145116">{{cite journal |vauthors=Napodano M, Tarantini G, Ramondo A, Cacciavillani L, Corbetti F, Marra MP, Fraccaro C, Peluso D, Razzolini R, Iliceto S |title=Myocardial abnormalities underlying persistent ST-segment elevation after anterior myocardial infarction |journal=J Cardiovasc Med (Hagerstown) |volume=10 |issue=1 |pages=44–50 |year=2009 |pmid=19145116 |doi=10.2459/JCM.0b013e32831967b2 |url=}}</ref><ref name="pmid18809796">{{cite journal |vauthors=Maron MS, Finley JJ, Bos JM, Hauser TH, Manning WJ, Haas TS, Lesser JR, Udelson JE, Ackerman MJ, Maron BJ |title=Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy |journal=Circulation |volume=118 |issue=15 |pages=1541–9 |year=2008 |pmid=18809796 |doi=10.1161/CIRCULATIONAHA.108.781401 |url=}}</ref><ref name="pmid4812079">{{cite journal |vauthors=Bulkley BH, Roberts WC |title=Steroid therapy during acute myocardial infarction. A cause of delayed healing and of ventricular aneurysm |journal=Am. J. Med. |volume=56 |issue=2 |pages=244–50 |year=1974 |pmid=4812079 |doi= |url=}}</ref><ref name="pmid5659397">{{cite journal |vauthors=Mourdjinis A, Olsen E, Raphael MJ, Mounsey JP |title=Clinical diagnosis and prognosis of ventricular aneurysm |journal=Br Heart J |volume=30 |issue=4 |pages=497–513 |year=1968 |pmid=5659397 |pmc=487659 |doi= |url=}}</ref>
The most potent risk factor for the development of the LV aneurysm is '''[[ST elevation myocardial infarction|ST elevation MI]]'''. Other risk factors include:<ref name="pmid19145116">{{cite journal |vauthors=Napodano M, Tarantini G, Ramondo A, Cacciavillani L, Corbetti F, Marra MP, Fraccaro C, Peluso D, Razzolini R, Iliceto S |title=Myocardial abnormalities underlying persistent ST-segment elevation after anterior myocardial infarction |journal=J Cardiovasc Med (Hagerstown) |volume=10 |issue=1 |pages=44–50 |year=2009 |pmid=19145116 |doi=10.2459/JCM.0b013e32831967b2 |url=}}</ref><ref name="pmid18809796">{{cite journal |vauthors=Maron MS, Finley JJ, Bos JM, Hauser TH, Manning WJ, Haas TS, Lesser JR, Udelson JE, Ackerman MJ, Maron BJ |title=Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy |journal=Circulation |volume=118 |issue=15 |pages=1541–9 |year=2008 |pmid=18809796 |doi=10.1161/CIRCULATIONAHA.108.781401 |url=}}</ref><ref name="pmid4812079">{{cite journal |vauthors=Bulkley BH, Roberts WC |title=Steroid therapy during acute myocardial infarction. A cause of delayed healing and of ventricular aneurysm |journal=Am. J. Med. |volume=56 |issue=2 |pages=244–50 |year=1974 |pmid=4812079 |doi= |url=}}</ref><ref name="pmid5659397">{{cite journal |vauthors=Mourdjinis A, Olsen E, Raphael MJ, Mounsey JP |title=Clinical diagnosis and prognosis of ventricular aneurysm |journal=Br Heart J |volume=30 |issue=4 |pages=497–513 |year=1968 |pmid=5659397 |pmc=487659 |doi= |url=}}</ref>
*[[Hypertrophic cardiomyopathy]] (HCM)
*[[Hypertrophic cardiomyopathy]] (HCM)
*[[Dilated cardiomyopathy]] (DCM)
*[[Dilated cardiomyopathy]] (DCM)

Latest revision as of 03:59, 9 April 2017

Left ventricular aneurysm Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Left ventricular aneurysm from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Left ventricular aneurysm risk factors On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Left ventricular aneurysm risk factors

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Left ventricular aneurysm risk factors

CDC on Left ventricular aneurysm risk factors

Left ventricular aneurysm risk factors in the news

Blogs on Left ventricular aneurysm risk factors

Directions to Hospitals Treating Left ventricular aneurysm

Risk calculators and risk factors for Left ventricular aneurysm risk factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Seyedmahdi Pahlavani, M.D. [2]

Overview

The common risk factors for developing LV aneurysm include ST elevation MI, hypertrophic cardiomyopathy (HCM), dilated cardiomyopathy (DCM), advanced age, and hypertension.

Risk Factors

The most potent risk factor for the development of the LV aneurysm is ST elevation MI. Other risk factors include:[1][2][3][4]

References

  1. Napodano M, Tarantini G, Ramondo A, Cacciavillani L, Corbetti F, Marra MP, Fraccaro C, Peluso D, Razzolini R, Iliceto S (2009). "Myocardial abnormalities underlying persistent ST-segment elevation after anterior myocardial infarction". J Cardiovasc Med (Hagerstown). 10 (1): 44–50. doi:10.2459/JCM.0b013e32831967b2. PMID 19145116.
  2. Maron MS, Finley JJ, Bos JM, Hauser TH, Manning WJ, Haas TS, Lesser JR, Udelson JE, Ackerman MJ, Maron BJ (2008). "Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy". Circulation. 118 (15): 1541–9. doi:10.1161/CIRCULATIONAHA.108.781401. PMID 18809796.
  3. Bulkley BH, Roberts WC (1974). "Steroid therapy during acute myocardial infarction. A cause of delayed healing and of ventricular aneurysm". Am. J. Med. 56 (2): 244–50. PMID 4812079.
  4. Mourdjinis A, Olsen E, Raphael MJ, Mounsey JP (1968). "Clinical diagnosis and prognosis of ventricular aneurysm". Br Heart J. 30 (4): 497–513. PMC 487659. PMID 5659397.


Template:WikiDoc Sources